Fungal Infections Clinical Trial
Phase I Clinical Trial for Comparison of Pharmacokinetic Characteristics of Vorico Injection 200mg(Voriconazole) and Vfend® IV 200mg for Single Dose Crossover Intravenous Infusion in Healthy Volunteers
To healthy volunteers subjects of twenty four(24), following treatments are administered
dosing in each period injected wash-out period is a minimum of 7days. Treatment A(Test Drug):
Vorico Injection 200mg(Voriconazole) for Single Dose Treatment B(Reference Drug): Vfend® IV
200mg for Single Dose Pharmacokinetic blood samples are collected up to 24hrs.
Safety and pharmacokinetic are assessed.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01782131 -
A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis (MK-5592-069)
|
Phase 3 | |
| Completed |
NCT00177684 -
Pharmacokinetic Profiles of Inhaled Lipid Complex Amphotericin B (Abelcet ®)
|
Phase 3 | |
| Recruiting |
NCT01684189 -
Registry of Febrile Neutropenia and Invasive Fungal Infections
|
N/A | |
| Completed |
NCT00794703 -
A Study to Compare Efficacy and Safety of Mycamine® and Itraconazole for Preventing Fungal Infections
|
Phase 3 | |
| Completed |
NCT00606268 -
A Study of Safety and Pharmacokinetics of Repeated Dose of Micafungin as Antifungal Prophylaxis in Children and Adolescents Who Undergo Hematopoietic Stem Cell Transplant
|
Phase 1 | |
| Completed |
NCT00353158 -
A Pilot of Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of Phototoxicity
|
Phase 1 | |
| Completed |
NCT01777763 -
Pharmacokinetics and Safety of Posaconazole Tablet in Participants at High Risk for Invasive Fungal Infections (MK-5592-065/P05615)
|
Phase 1 | |
| Recruiting |
NCT01222741 -
Studies of Disorders With Increased Susceptibility to Fungal Infections
|
||
| Completed |
NCT02358499 -
Genetic Variation and Variability in Posaconazole Pharmacokinetics in Children
|
Phase 1 | |
| Completed |
NCT00177710 -
Pharmacokinetic Profile of Inhaled Liposomal Amphotericin B in Lung Transplant Recipients - Ambisome Study
|
Phase 3 | |
| Enrolling by invitation |
NCT03793231 -
fungalAi for Fungal Surveillance & Antifungal Stewardship
|
||
| Completed |
NCT02025699 -
Prospective Study to Characterize Host-pathogen Related Factors in Hospitalized and ED Patients With LRTI and/or Sepsis
|
N/A | |
| Completed |
NCT01436578 -
Safety and Efficacy of Posaconazole Oral Suspension in Usual Practice in Korea (P08547)
|
N/A | |
| Completed |
NCT00876096 -
Interest of Real-time Polymerase Chain Reaction (PCR) in the Diagnosis of Fungal Infections
|
N/A | |
| Completed |
NCT02306330 -
MALDITOF Versus Routine Clinical Microbiology for Identifying Pathogens; a Randomized Diagnostic Trial
|
N/A | |
| Not yet recruiting |
NCT01105013 -
Evaluate the Efficacy and Safety of Tolnaftate Cream in the Treatment of Patients With Fungal Infections
|
Phase 3 | |
| Terminated |
NCT01716234 -
A Study of the Safety, Tolerance, and Pharmacokinetics of Oral Posaconazole in Immunocompromised Children (P03579)
|
Phase 1 | |
| Recruiting |
NCT05336851 -
Emergency PWAS in Respiratory Infectious Disease
|